19 August 2024
Science Group plc
(the "Company" or "Science Group")
Executive Chair Share Purchase
Science Group plc (AIM:SAG) announces that it has been notified by Martyn Ratcliffe, Executive Chair of the Company, that on 16 August 2024 he purchased 10,000 ordinary shares of 1p each in the Company at a price of 450 pence per share for his SIPP.
Following this, Martyn Ratcliffe has an interest in 9,422,080 ordinary shares in the Company (being approximately 20.73% of the issued share capital excluding treasury shares). All other Directors' beneficial interests in the share capital of the Company remain unchanged and as previously announced.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name: Martyn Ratcliffe | ||||
2. | Reason for the notification | ||||
| a) | Position/status: Executive Chair | ||||
| b) | Initial notification/Amendment: Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name: Science Group plc | ||||
| b) | LEI: 2138009OJQT79BDB3E93 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument: Ordinary shares of 1p each. Identification code: GB00B39GTJ17 | ||||
| b) | Nature of the transaction: Acquisition of shares | ||||
| c) | Price(s) and volume(s):
| ||||
| d) | Aggregated information: · Aggregated volume: 10000 · Price: £45,000 | ||||
| e) | Date of the transaction: 2024-08-16 | ||||
| f) | Place of the transaction: AIMX |
- Ends -
| For further information:
| |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
